Consulate General of Canada in Shanghai China

For more than 120 years, the Trade Commissioner Service (TCS) has been helping Canadian companies navigate international markets. Our trade commissioners in more than 160 cities worldwide can provide you with key business insights and access to an unbeatable network of international contacts. The TCS provides Canadian businesses and organizations with tailored advice to help them enter new markets outside of Canada.
Lulu Mi
Life Sciences Trade Commissioner 
Functionality
Dr Kshitij Soni
LinkedIn logo CEO 
Functionality

Global Clinical Trials (GCT) United States

Global Clinical Trials (GCT) is a premium contract-research organization (CRO) that offers support for the clinical Phase I-IV studies as well as post-marketing activities to Big Pharma, small and medium-sized biotech enterprises, groups and funds, as well as large universities and institutions. Headquartered in Princeton, USA, GCT offers both local and global support through 10 own operational offices in Bulgaria, Czech Republic, Georgia, Hungary, India, Kazakhstan, Latvia, Lithuania, Estonia, Moldova, Poland, Romania, Russia, Slovakia, Ukraine.
GCT team, that now consists of over 100 full-time clinical research professionals, gives individualized attention to each project and provides full range of services following the latest GCP, EMA and FDA guidelines at every stage of product development path. Our monitors and project managers are all certified clinicians experienced in GCP clinical research. Our experience, competent staff, close contact with the KOLs and the immense enrollment potential of the covered region ensure fast study start-up and compliance with the set timelines.
GCT owns 400 sq.m. (4300 ft2) Drug Storage and Distribution facility in St. Petersburg, Russia. It is fully equipped, disaster protected and has multiple modes of storage (ambient, climate controlled, refrigerated, frozen). High standards of work and client satisfaction are proved by the fact that more than 80% of the business come from repeat clients.
Since 2006 GCT is also an Exclusive Partner of “The White Nights” International ophthalmology congress in Russia.
Company Size (Fulltime employees)
Year of foundation
2001
Stock Market and Ticker/Symbol/Number
N/A
Please specify your partnering goal
Networking, new business opportunities
Headquartner in China
Plan in China
GCT is looking for potential new business opportunities, offering full-service clinical trials support worldwide for Chinese pharma companies.
Biotech/Pharma Category
Biotech/Pharma Asset Stage
Medtech Development Stage
Your Service Name
clinical trials, market authorization, registration, consulting
Service Description
logistics, regulatory services, project and site management, pharmacovigilance, medical monitoring, data management, biostatistics, medical writing, GDPR and DPO, EU Legal representation,
Target Client Type
Pharma, Biotech, Device companies
Aleksandr Stiblo
LinkedIn logo Director, Business Development 
Functionality

NeuroZone Italy

Neuro-Zone, since 13 years, supports drug discovery, drug repurposing and research projects in the fields of inflammation and age-related pathologies.
In particular, we have developed pathology-specific platforms to generate rapid and informative data on efficacy, toxicity, metabolism and mechanism of action, supported by proprietary technologies such as MicroTISSUE (dissecting microenvironment-cell interaction in complex inflammatory scenarios) or MITOS (a comprehensive analytical platform for quantitative analysis of mitochondrial function ).
Our approach enables effective selection and ranking of the most promising candidates per indication.
Moreover, we profile candidates at different level of complexity starting from:
a) pharmacology profiling (GPCR; Ion Channel receptors)
b) identification of biochemical pathways responsible for therapeutic efficacy (transcriptomics)
c) disease modified barrier permeability (BBB and endothelial)
Company Size (Fulltime employees)
Year of foundation
2007
Please specify your partnering goal
Commercial partnership in China(representative office in Shanghai expected to open January 2021)
Headquartner in China
Plan in China
Representative office to be established in January 2021 In Shanghai
Fabio Bianco
President 
Functionality

WPD Pharmaceuticals Canada

WPD has 8 novel drug candidates with 4 that are in clinical development stage and 4 in pre-clinical development. These drug candidates were researched at institutions including the Mayo Clinic and Emory University, and WPD currently has ongoing collaborations with Wake Forest University and leading hospitals and academic centers in Poland.

Alongside direct investment of $60 million, over $29 million of grant funding (total of $89 million USD) has gone towards the development of our robust drug development pipeline with a focus on melanoma, brain cancer, leukemia, and pancreatic cancer. Notably, these funds do not include $14 million USD in grants recently awarded to WPD Pharmaceuticals from The National Centre for Research and Development in Poland.

With a groundswell of multi-continental grant support and a diverse portfolio of breakthrough drug technologies, WPD Pharmaceuticals is now strategically positioned to enter the market with blockbuster potential.

Company Size (Fulltime employees)
Year of foundation
2017
Stock Market and Ticker/Symbol/Number
WCSE: BIO
Please specify your partnering goal
We are looking for investors and partners for co-develop our product in China and co-develop partner product in EU.
Now raising (In USD)
between $ 3 million - $10 million
Headquartner in China
Plan in China
We are looking for investors and partners for co-develop our product in China and co-develop partner product in EU.
Investment Focus
Seeking funding to move from pre clinical stage to Phase 1/2 clinical trial and support co-development in EU
Mariusz Olejniczak
CEO 
Functionality

华润双鹤药业 China

央企,从事药品研发,生产,销售,产品超过300个,2019年营业收入将近100亿元,共有400人的研发团队,全国分布19个生产基地,销售网络遍布全国各省,销售团队超过2500人。希望寻找高壁垒仿制药,高端技术平台,505b2,创新化药,生物药&生物类似物的合作机会,合作方式灵活。
怡 李
BD经理